Search research articles
Contact Us
Filters
Showing results (21-30 of 62) with videos related to
Page
of 7
Sort By:
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
September 5, 2012
Metachronous colorectal cancer risk in patients with a moderate family history
K F Newton, K Green, S Walsh, et al.
International Journal of Surgical Oncology
|
February 8, 2012
Hyperplastic polyps are innocuous lesions in hereditary nonpolyposis colorectal cancers
D Speake, J O'Sullivan, D G Evans, et al.
American Journal of Medical Genetics. Part A
|
January 19, 2010
Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service
D G Evans, E Howard, C Giblin, et al.
Familial Cancer
|
October 24, 2003
Familial breast cancer: an investigation into the outcome of treatment for early stage disease
D Eccles, P Simmonds, J Goddard, et al.
Psycho-Oncology
|
February 17, 2001
Clinical follow-up after bilateral risk reducing ('prophylactic') mastectomy: mental health and body image outcomes
P Hopwood, A Lee, A Shenton, et al.
Familial Cancer
|
August 5, 2015
Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis
N N Basu, S Ingham, J Hodson, et al.
Clinical Genetics
|
October 12, 2012
Is multiple SNP testing in BRCA2 and BRCA1 female carriers ready for use in clinical practice? Results from a large Genetic Centre in the UK
S L Ingham, J Warwick, H Byers, et al.
Clinical Genetics
|
June 17, 2008
Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations
E Barrow, W Alduaij, L Robinson, et al.
Clinical Genetics
|
February 14, 2009
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations
E Barrow, L Robinson, W Alduaij, et al.
Journal of Medical Genetics
|
June 23, 2009
Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing
D G R Evans, F Lalloo, A Cramer, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 62) with videos related to
Sort By:
Page
of 7
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
September 5, 2012
Metachronous colorectal cancer risk in patients with a moderate family history
K F Newton, K Green, S Walsh, et al.
International Journal of Surgical Oncology
|
February 8, 2012
Hyperplastic polyps are innocuous lesions in hereditary nonpolyposis colorectal cancers
D Speake, J O'Sullivan, D G Evans, et al.
American Journal of Medical Genetics. Part A
|
January 19, 2010
Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service
D G Evans, E Howard, C Giblin, et al.
Familial Cancer
|
October 24, 2003
Familial breast cancer: an investigation into the outcome of treatment for early stage disease
D Eccles, P Simmonds, J Goddard, et al.
Psycho-Oncology
|
February 17, 2001
Clinical follow-up after bilateral risk reducing ('prophylactic') mastectomy: mental health and body image outcomes
P Hopwood, A Lee, A Shenton, et al.
Familial Cancer
|
August 5, 2015
Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis
N N Basu, S Ingham, J Hodson, et al.
Clinical Genetics
|
October 12, 2012
Is multiple SNP testing in BRCA2 and BRCA1 female carriers ready for use in clinical practice? Results from a large Genetic Centre in the UK
S L Ingham, J Warwick, H Byers, et al.
Clinical Genetics
|
June 17, 2008
Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations
E Barrow, W Alduaij, L Robinson, et al.
Clinical Genetics
|
February 14, 2009
Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations
E Barrow, L Robinson, W Alduaij, et al.
Journal of Medical Genetics
|
June 23, 2009
Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing
D G R Evans, F Lalloo, A Cramer, et al.
Page
of 7